Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,775,000 | 1,883,000 | 3,604,000 | 2,727,000 | 2,745,000 |
| Receivables | 15,154,000 | 14,657,000 | 12,542,000 | 14,964,000 | 14,036,000 |
| Inventories | 3,431,000 | 3,144,000 | 2,981,000 | 2,903,000 | 3,119,000 |
| Other current assets | 613,000 | 706,000 | 688,000 | 763,000 | 774,000 |
| TOTAL | $20,973,000 | $20,390,000 | $19,815,000 | $21,357,000 | $20,674,000 |
| Non-Current Assets | |||||
| PPE Net | 7,569,000 | 7,561,000 | 7,597,000 | 7,332,000 | 7,290,000 |
| Intangibles | 13,378,000 | 13,455,000 | 13,519,000 | 13,583,000 | 13,659,000 |
| Other Non-Current Assets | 9,838,000 | 10,104,000 | 9,942,000 | 9,571,000 | 10,476,000 |
| TOTAL | $30,785,000 | $31,120,000 | $31,058,000 | $30,486,000 | $31,425,000 |
| Total Assets | $51,758,000 | $51,510,000 | $50,873,000 | $51,843,000 | $52,099,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 500,000 | 6,000 | 6,000 | 506,000 |
| Accounts payable and accrued liabilities | 2,309,000 | 2,599,000 | 780,000 | 1,520,000 | 1,608,000 |
| Accrued Expenses | 2,935,000 | 2,671,000 | 3,108,000 | 3,122,000 | 3,029,000 |
| Other current liabilities | 3,158,000 | 2,375,000 | 1,996,000 | 2,863,000 | 2,720,000 |
| TOTAL | $16,479,000 | $16,047,000 | $13,997,000 | $15,026,000 | $15,242,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,644,000 | 11,145,000 | 11,670,000 | 11,668,000 | 11,665,000 |
| Deferred Revenues | 8,077,000 | 7,902,000 | 8,107,000 | 7,515,000 | 7,379,000 |
| Other Non-Current Liabilities | 12,203,000 | 14,316,000 | 14,247,000 | 15,518,000 | 18,654,000 |
| TOTAL | $23,847,000 | $25,461,000 | $25,917,000 | $27,186,000 | $30,327,000 |
| Total Liabilities | $40,326,000 | $41,508,000 | $39,914,000 | $42,212,000 | $45,569,000 |
| Shareholders' Equity | |||||
| Common Shares | 264,000 | 265,000 | 271,000 | 274,000 | 276,000 |
| Retained earnings | 19,336,000 | 20,716,000 | 21,600,000 | 21,476,000 | 21,961,000 |
| Other shareholders' equity | -8,168,000 | -10,979,000 | -11,006,000 | -12,217,000 | -15,837,000 |
| TOTAL | $11,432,000 | $10,002,000 | $10,959,000 | $9,631,000 | $6,522,000 |
| Total Liabilities And Equity | $51,758,000 | $51,510,000 | $50,873,000 | $51,843,000 | $52,091,000 |